CN Stock MarketDetailed Quotes

600196 Shanghai Fosun Pharmaceutical

Watchlist
  • 22.59
  • +0.02+0.09%
Market Closed Jul 12 15:00 CST
60.37BMarket Cap30.04P/E (TTM)

Shanghai Fosun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-6.56%10.16B
-5.81%41.4B
-2.92%30.7B
0.22%21.4B
4.68%10.87B
12.66%43.95B
16.91%31.62B
25.93%21.35B
28.91%10.38B
28.72%39.01B
Operating revenue
-6.56%10.16B
-5.81%41.4B
-2.92%30.7B
0.22%21.4B
4.68%10.87B
12.66%43.95B
16.91%31.62B
25.93%21.35B
28.91%10.38B
28.72%39.01B
Other operating revenue
----
-14.93%488.71M
----
17.95%271.59M
----
66.24%574.48M
----
57.70%230.25M
----
-12.94%345.58M
Total operating cost
-5.70%9.52B
-0.15%41.28B
2.86%30.28B
5.10%20.63B
4.19%10.1B
11.47%41.35B
15.80%29.44B
23.52%19.63B
29.87%9.69B
29.72%37.09B
Operating cost
-4.10%5.08B
-6.80%21.6B
-6.70%15.78B
-7.60%10.7B
-9.67%5.29B
14.53%23.17B
24.03%16.91B
40.23%11.58B
50.91%5.86B
47.30%20.23B
Operating tax surcharges
37.93%92.44M
19.08%271.26M
20.13%197.96M
26.88%137.57M
25.41%67.02M
-2.85%227.8M
-4.66%164.78M
-5.83%108.43M
-4.82%53.44M
7.88%234.47M
Operating expense
-10.93%2.24B
5.90%9.71B
11.23%7.23B
21.46%5.07B
21.59%2.52B
0.77%9.17B
-0.94%6.5B
-0.86%4.18B
-0.51%2.07B
11.51%9.1B
Administration expense
1.13%1B
14.28%4.37B
20.61%3.17B
21.77%2.05B
25.25%991.09M
18.63%3.83B
16.73%2.63B
14.66%1.68B
17.46%791.31M
8.92%3.23B
Financial expense
7.26%280.22M
52.04%984.32M
99.46%756.08M
107.78%545.37M
144.12%261.26M
39.52%647.4M
-3.66%379.07M
-7.25%262.47M
-16.70%107.02M
-35.93%464.02M
-Interest expense (Financial expense)
22.14%348.09M
37.46%1.32B
35.63%947.67M
37.47%603.38M
37.57%285.01M
17.17%963.81M
10.54%698.73M
4.32%438.91M
1.04%207.17M
-6.63%822.54M
-Interest Income (Financial expense)
-10.60%-99.67M
-28.66%-363.65M
-34.00%-265.61M
-44.82%-171.49M
-64.43%-90.12M
-20.90%-282.63M
-13.59%-198.22M
-1.56%-118.42M
5.53%-54.81M
-17.12%-233.78M
Research and development
-14.38%829.57M
1.02%4.35B
10.22%3.16B
16.81%2.13B
19.66%968.87M
12.11%4.3B
18.60%2.86B
16.98%1.83B
26.35%809.68M
37.27%3.84B
Credit Impairment Loss
-32.24%-16.41M
-101.82%-131.93M
-133.73%-81.58M
-153.61%-57.98M
-87.81%-12.41M
11.68%-65.37M
-71.58%-34.9M
-54.42%-22.86M
-1,767.32%-6.61M
29.40%-74.02M
Asset Impairment Loss
144.64%5.89M
19.36%-219.74M
-210.83%-290.9M
-22.93%-91.66M
-2,158.02%-13.18M
67.17%-272.49M
62.00%-93.59M
64.04%-74.57M
108.85%640.65K
-459.77%-829.87M
Other net revenue
-40.96%386.54M
55.61%3.19B
111.83%2.93B
137.03%1.92B
239.14%654.7M
-53.21%2.05B
-55.10%1.38B
-64.29%809.8M
-65.90%193.05M
45.72%4.38B
Fair value change income
86.36%-20.14M
82.89%-427.38M
141.76%806.34M
127.49%387.37M
89.13%-147.61M
-809.16%-2.5B
-245.96%-1.93B
-219.16%-1.41B
-2,628.67%-1.36B
-39.12%352.3M
Invest income
-56.19%335.56M
-20.01%3.5B
-28.53%2.18B
-32.02%1.47B
-49.17%765.9M
-5.32%4.38B
65.13%3.05B
85.12%2.17B
218.02%1.51B
102.45%4.62B
-Including: Investment income associates
-9.83%330.32M
19.06%2.18B
22.55%1.5B
27.94%1.02B
14.94%366.34M
2.57%1.84B
-7.60%1.22B
-3.94%799.02M
23.26%318.73M
13.21%1.79B
Asset deal income
185.51%434.1K
-95.57%5.56M
-95.50%6.3M
-52.88%804.99K
-173.65%-507.68K
914.61%125.6M
2,026.44%140.1M
-40.15%1.71M
-120.77%-185.52K
-370.15%-15.42M
Other revenue
29.93%81.22M
20.66%463.54M
22.92%303.79M
40.75%207.54M
24.13%62.51M
17.18%384.15M
38.44%247.15M
10.28%147.45M
10.89%50.36M
-16.71%327.83M
Operating profit
-28.43%1.02B
-28.97%3.31B
-6.14%3.34B
6.17%2.68B
61.11%1.43B
-26.11%4.66B
-24.23%3.56B
-24.07%2.53B
-23.60%885.83M
33.50%6.3B
Add:Non operating Income
65.62%9.31M
61.10%57.12M
195.83%49.59M
178.55%24.21M
-13.10%5.62M
23.72%35.46M
-27.44%16.76M
-58.50%8.69M
68.66%6.47M
24.16%28.66M
Less:Non operating expense
-74.47%12.25M
-15.01%100.06M
-51.89%99.33M
-71.94%51.35M
224.95%48M
-59.20%117.73M
267.97%206.48M
311.80%183.02M
-18.51%14.77M
334.67%288.56M
Total profit
-26.46%1.02B
-28.63%3.26B
-2.33%3.29B
12.89%2.66B
57.80%1.38B
-24.30%4.57B
-27.76%3.37B
-28.81%2.35B
-23.37%877.53M
29.18%6.04B
Less:Income tax cost
-14.16%232.2M
-41.06%369.5M
4.43%638.65M
19.87%610.24M
11.16%270.51M
-41.21%626.92M
-16.37%611.54M
-7.55%509.09M
46.15%243.36M
44.53%1.07B
Net profit
-29.44%786.22M
-26.66%2.9B
-3.83%2.65B
10.96%2.05B
75.70%1.11B
-20.67%3.95B
-29.87%2.76B
-33.06%1.84B
-35.20%634.16M
26.30%4.98B
Net profit from continuing operation
-29.44%786.22M
-26.66%2.9B
-3.83%2.65B
10.96%2.05B
75.70%1.11B
-20.67%3.95B
-29.87%2.76B
-33.06%1.84B
-35.20%634.16M
26.30%4.98B
Less:Minority Profit
38.66%176.49M
134.84%508.8M
14.66%370.74M
-12.93%267.75M
-28.33%127.28M
-12.48%216.66M
-12.66%323.34M
13.38%307.51M
35.08%177.59M
-10.68%247.56M
Net profit of parent company owners
-38.22%609.73M
-36.04%2.39B
-6.29%2.28B
15.74%1.78B
116.17%986.97M
-21.10%3.73B
-31.66%2.44B
-38.14%1.54B
-46.11%456.57M
29.10%4.73B
Earning per share
Basic earning per share
-37.84%0.23
-37.76%0.89
-8.51%0.86
11.67%0.67
105.56%0.37
-22.70%1.43
-32.37%0.94
-38.14%0.6
-45.45%0.18
29.37%1.85
Diluted earning per share
-37.84%0.23
-37.76%0.89
-9.57%0.85
11.67%0.67
105.56%0.37
-22.70%1.43
-32.37%0.94
-38.14%0.6
-45.45%0.18
29.37%1.85
Other composite income
149.68%91.15M
-70.51%31.86M
-14.95%383.05M
1,180.86%475.61M
31.68%-183.49M
131.39%108.04M
354.75%450.4M
128.03%37.13M
-470.83%-268.58M
41.65%-344.18M
Other composite income of parent company owners
149.48%75.5M
-135.23%-35.44M
-20.51%219.2M
275.82%258.82M
18.44%-152.6M
130.28%100.61M
300.31%275.77M
170.78%68.87M
-338.50%-187.11M
38.90%-332.25M
Other composite income of minority owners
150.69%15.65M
805.34%67.3M
-6.18%163.84M
783.06%216.78M
62.09%-30.89M
162.32%7.43M
546.28%174.63M
9.73%-31.74M
-1,251.66%-81.47M
74.09%-11.93M
Total composite income
-5.74%877.38M
-27.83%2.93B
-5.39%3.04B
34.06%2.52B
154.60%930.77M
-12.45%4.06B
-14.59%3.21B
-28.26%1.88B
-65.22%365.59M
38.27%4.63B
Total composite income of parent company owners
-17.87%685.23M
-38.64%2.35B
-7.73%2.5B
26.90%2.04B
209.65%834.37M
-12.85%3.83B
-20.87%2.71B
-32.72%1.6B
-70.89%269.46M
40.96%4.4B
Total composite income of minority owners
99.33%192.14M
157.08%576.1M
7.35%534.59M
75.70%484.54M
0.28%96.4M
-4.90%224.09M
50.41%497.96M
16.83%275.77M
-23.37%96.13M
1.94%235.63M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -6.56%10.16B-5.81%41.4B-2.92%30.7B0.22%21.4B4.68%10.87B12.66%43.95B16.91%31.62B25.93%21.35B28.91%10.38B28.72%39.01B
Operating revenue -6.56%10.16B-5.81%41.4B-2.92%30.7B0.22%21.4B4.68%10.87B12.66%43.95B16.91%31.62B25.93%21.35B28.91%10.38B28.72%39.01B
Other operating revenue -----14.93%488.71M----17.95%271.59M----66.24%574.48M----57.70%230.25M-----12.94%345.58M
Total operating cost -5.70%9.52B-0.15%41.28B2.86%30.28B5.10%20.63B4.19%10.1B11.47%41.35B15.80%29.44B23.52%19.63B29.87%9.69B29.72%37.09B
Operating cost -4.10%5.08B-6.80%21.6B-6.70%15.78B-7.60%10.7B-9.67%5.29B14.53%23.17B24.03%16.91B40.23%11.58B50.91%5.86B47.30%20.23B
Operating tax surcharges 37.93%92.44M19.08%271.26M20.13%197.96M26.88%137.57M25.41%67.02M-2.85%227.8M-4.66%164.78M-5.83%108.43M-4.82%53.44M7.88%234.47M
Operating expense -10.93%2.24B5.90%9.71B11.23%7.23B21.46%5.07B21.59%2.52B0.77%9.17B-0.94%6.5B-0.86%4.18B-0.51%2.07B11.51%9.1B
Administration expense 1.13%1B14.28%4.37B20.61%3.17B21.77%2.05B25.25%991.09M18.63%3.83B16.73%2.63B14.66%1.68B17.46%791.31M8.92%3.23B
Financial expense 7.26%280.22M52.04%984.32M99.46%756.08M107.78%545.37M144.12%261.26M39.52%647.4M-3.66%379.07M-7.25%262.47M-16.70%107.02M-35.93%464.02M
-Interest expense (Financial expense) 22.14%348.09M37.46%1.32B35.63%947.67M37.47%603.38M37.57%285.01M17.17%963.81M10.54%698.73M4.32%438.91M1.04%207.17M-6.63%822.54M
-Interest Income (Financial expense) -10.60%-99.67M-28.66%-363.65M-34.00%-265.61M-44.82%-171.49M-64.43%-90.12M-20.90%-282.63M-13.59%-198.22M-1.56%-118.42M5.53%-54.81M-17.12%-233.78M
Research and development -14.38%829.57M1.02%4.35B10.22%3.16B16.81%2.13B19.66%968.87M12.11%4.3B18.60%2.86B16.98%1.83B26.35%809.68M37.27%3.84B
Credit Impairment Loss -32.24%-16.41M-101.82%-131.93M-133.73%-81.58M-153.61%-57.98M-87.81%-12.41M11.68%-65.37M-71.58%-34.9M-54.42%-22.86M-1,767.32%-6.61M29.40%-74.02M
Asset Impairment Loss 144.64%5.89M19.36%-219.74M-210.83%-290.9M-22.93%-91.66M-2,158.02%-13.18M67.17%-272.49M62.00%-93.59M64.04%-74.57M108.85%640.65K-459.77%-829.87M
Other net revenue -40.96%386.54M55.61%3.19B111.83%2.93B137.03%1.92B239.14%654.7M-53.21%2.05B-55.10%1.38B-64.29%809.8M-65.90%193.05M45.72%4.38B
Fair value change income 86.36%-20.14M82.89%-427.38M141.76%806.34M127.49%387.37M89.13%-147.61M-809.16%-2.5B-245.96%-1.93B-219.16%-1.41B-2,628.67%-1.36B-39.12%352.3M
Invest income -56.19%335.56M-20.01%3.5B-28.53%2.18B-32.02%1.47B-49.17%765.9M-5.32%4.38B65.13%3.05B85.12%2.17B218.02%1.51B102.45%4.62B
-Including: Investment income associates -9.83%330.32M19.06%2.18B22.55%1.5B27.94%1.02B14.94%366.34M2.57%1.84B-7.60%1.22B-3.94%799.02M23.26%318.73M13.21%1.79B
Asset deal income 185.51%434.1K-95.57%5.56M-95.50%6.3M-52.88%804.99K-173.65%-507.68K914.61%125.6M2,026.44%140.1M-40.15%1.71M-120.77%-185.52K-370.15%-15.42M
Other revenue 29.93%81.22M20.66%463.54M22.92%303.79M40.75%207.54M24.13%62.51M17.18%384.15M38.44%247.15M10.28%147.45M10.89%50.36M-16.71%327.83M
Operating profit -28.43%1.02B-28.97%3.31B-6.14%3.34B6.17%2.68B61.11%1.43B-26.11%4.66B-24.23%3.56B-24.07%2.53B-23.60%885.83M33.50%6.3B
Add:Non operating Income 65.62%9.31M61.10%57.12M195.83%49.59M178.55%24.21M-13.10%5.62M23.72%35.46M-27.44%16.76M-58.50%8.69M68.66%6.47M24.16%28.66M
Less:Non operating expense -74.47%12.25M-15.01%100.06M-51.89%99.33M-71.94%51.35M224.95%48M-59.20%117.73M267.97%206.48M311.80%183.02M-18.51%14.77M334.67%288.56M
Total profit -26.46%1.02B-28.63%3.26B-2.33%3.29B12.89%2.66B57.80%1.38B-24.30%4.57B-27.76%3.37B-28.81%2.35B-23.37%877.53M29.18%6.04B
Less:Income tax cost -14.16%232.2M-41.06%369.5M4.43%638.65M19.87%610.24M11.16%270.51M-41.21%626.92M-16.37%611.54M-7.55%509.09M46.15%243.36M44.53%1.07B
Net profit -29.44%786.22M-26.66%2.9B-3.83%2.65B10.96%2.05B75.70%1.11B-20.67%3.95B-29.87%2.76B-33.06%1.84B-35.20%634.16M26.30%4.98B
Net profit from continuing operation -29.44%786.22M-26.66%2.9B-3.83%2.65B10.96%2.05B75.70%1.11B-20.67%3.95B-29.87%2.76B-33.06%1.84B-35.20%634.16M26.30%4.98B
Less:Minority Profit 38.66%176.49M134.84%508.8M14.66%370.74M-12.93%267.75M-28.33%127.28M-12.48%216.66M-12.66%323.34M13.38%307.51M35.08%177.59M-10.68%247.56M
Net profit of parent company owners -38.22%609.73M-36.04%2.39B-6.29%2.28B15.74%1.78B116.17%986.97M-21.10%3.73B-31.66%2.44B-38.14%1.54B-46.11%456.57M29.10%4.73B
Earning per share
Basic earning per share -37.84%0.23-37.76%0.89-8.51%0.8611.67%0.67105.56%0.37-22.70%1.43-32.37%0.94-38.14%0.6-45.45%0.1829.37%1.85
Diluted earning per share -37.84%0.23-37.76%0.89-9.57%0.8511.67%0.67105.56%0.37-22.70%1.43-32.37%0.94-38.14%0.6-45.45%0.1829.37%1.85
Other composite income 149.68%91.15M-70.51%31.86M-14.95%383.05M1,180.86%475.61M31.68%-183.49M131.39%108.04M354.75%450.4M128.03%37.13M-470.83%-268.58M41.65%-344.18M
Other composite income of parent company owners 149.48%75.5M-135.23%-35.44M-20.51%219.2M275.82%258.82M18.44%-152.6M130.28%100.61M300.31%275.77M170.78%68.87M-338.50%-187.11M38.90%-332.25M
Other composite income of minority owners 150.69%15.65M805.34%67.3M-6.18%163.84M783.06%216.78M62.09%-30.89M162.32%7.43M546.28%174.63M9.73%-31.74M-1,251.66%-81.47M74.09%-11.93M
Total composite income -5.74%877.38M-27.83%2.93B-5.39%3.04B34.06%2.52B154.60%930.77M-12.45%4.06B-14.59%3.21B-28.26%1.88B-65.22%365.59M38.27%4.63B
Total composite income of parent company owners -17.87%685.23M-38.64%2.35B-7.73%2.5B26.90%2.04B209.65%834.37M-12.85%3.83B-20.87%2.71B-32.72%1.6B-70.89%269.46M40.96%4.4B
Total composite income of minority owners 99.33%192.14M157.08%576.1M7.35%534.59M75.70%484.54M0.28%96.4M-4.90%224.09M50.41%497.96M16.83%275.77M-23.37%96.13M1.94%235.63M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg